Hedge Funds Are Selling Vical Incorporated (VICL)

Page 1 of 2

We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings show the funds’ and investors’ portfolio positions as of September 30. In this article we look at what those investors think of Vical Incorporated (NASDAQ:VICL).

Vical Incorporated (NASDAQ:VICL) was in 6 hedge funds’ portfolios at the end of the third quarter of 2015. VICL has experienced a decrease in support from the world’s most elite money managers of late. There were 8 hedge funds in our database with VICL holdings at the end of the previous quarter. At the end of this article we will also compare VICL to other stocks including Intersections Inc. (NASDAQ:INTX), Christopher & Banks Corporation (NYSE:CBK), and Cinedigm Corp (NASDAQ:CIDM) to get a better sense of its popularity.

Follow Fresh Tracks Therapeutics Inc. (NASDAQ:FRTX)

In the financial world there are a multitude of gauges stock market investors employ to value publicly traded companies. Two of the best gauges are hedge fund and insider trading indicators. We have shown that, historically, those who follow the top picks of the top fund managers can outpace the S&P 500 by a significant amount (see the details here).

Now, let’s take a look at the fresh action regarding Vical Incorporated (NASDAQ:VICL).

What does the smart money think about Vical Incorporated (NASDAQ:VICL)?

At the end of the third quarter, a total of 6 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of -25% from the second quarter. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Peter Kolchinsky’s RA Capital Management has the biggest position in Vical Incorporated (NASDAQ:VICL), worth close to $1 million, corresponding to 0.1% of its total 13F portfolio. On RA Capital Management’s heels is Renaissance Technologies, led by Jim Simons, holding a $0.5 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Some other hedge funds and institutional investors with similar optimism comprise John Overdeck and David Siegel’s Two Sigma Advisors, Murray Stahl’s Horizon Asset Management and Chao Ku’s Nine Chapters Capital Management.

Page 1 of 2